Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction: other studies

Currently viewing:

Administrative data

Endpoint:
toxicity to reproduction: other studies
Type of information:
experimental study
Adequacy of study:
disregarded due to major methodological deficiencies
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Investigative non-guideline study. With regard to hazard assessment, the findings reported by Adams et al. (1998) are considered to be of limited relevance because the subcutaneous injection does not represent a relevant exposure route. In addition, the precise s.c. injection site is not indicated in the publication, only one time point (2 hours after treatment) was studied and no microscopical examination of the testes was performed.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Imidazoles suppress rat testosterone secretion and testicular interstitial fluid formation in vivo
Author:
Adams ML, Meyer ER and Cicero TJ
Year:
1998
Bibliographic source:
Biol Reproduction 59: 248-254
Title:
No information
Author:
also cited in OECD SIDS Dossier Imidazole, Final August 2005

Materials and methods

Principles of method if other than guideline:
Increasing single doses of imidazole (10-300 mg/kg bw) were adminstered to rats (10 male rats per group) via subcutaneous injection and samples of serum an testicular interstitial fluid were investigated at a single time point (after 2 hours).
GLP compliance:
no
Type of method:
in vivo

Test material

Constituent 1
Chemical structure
Reference substance name:
Imidazole
EC Number:
206-019-2
EC Name:
Imidazole
Cas Number:
288-32-4
Molecular formula:
C3H4N2
IUPAC Name:
1H-imidazole
Details on test material:
- Name of test material (as cited in study report): Imidazole (Sigma Chemical Company (St. Louis))

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: originally derived from Harlan Sprague-Dawley, Inc. (Indianapolis, IN) rats
- Age at study initiation: Adult (60 days old) or adolescent (42 days old)

Administration / exposure

Route of administration:
subcutaneous
Vehicle:
physiological saline
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
Single
Frequency of treatment:
Once
Duration of test:
2 hours
Doses / concentrations
Remarks:
Doses / Concentrations:
10 – 300 mg/kg (122–4407 mmol/kg)
Basis:
nominal conc.
Control animals:
yes, concurrent vehicle
Statistics:
ANOVA followed by post hoc analysis with Fisher’s protected least-significant difference tests was used to determine significant differences between groups as described previously (Adams ML, Little PJ, Bell B, Cicero TJ. Alcohol affects rat testicular interstitial fluid volume and testicular secretion of testosterone and bendorphin. J Pharmacol Exp Ther 1991; 258:1008–1014.). The level of significance was set at p < 0.05.

Results and discussion

Observed effects

Imidazole decreased serum testosterone in a dose-dependent manner at 2 h after treatment. Imidazole dose-dependently also decreased TIF testosterone concentrations, TIF volume, and LH secretion.

Applicant's summary and conclusion